Center-Authored Papers

Filters: Author is Reed, Susan D  [Clear All Filters]
A
Allison KH, Tenpenny E, Reed SD, Swisher EM, Garica RL.  2008.  Immunohistochemical markers in endometrial hyperplasia: is there a panel with promise? A review. Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry. 16(4):329-43. Abstract
Allison KH, Reed SD, Voigt LF, Jordan CD, Newton KM, Garcia RL.  2008.  Diagnosing endometrial hyperplasia: why is it so difficult to agree? The American journal of surgical pathology. 32(5):691-8. Abstract
Allison KH, Upson K, Reed SD, Jordan CD, Newton KM, Doherty J, Swisher EM, Garcia RL.  2012.  PAX2 Loss by Immunohistochemistry Occurs Early and Often in Endometrial Hyperplasia.. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists. 31(2):151-159. Abstract
B
Beaber EF, Buist DSM, Barlow WE, Malone KE, Reed SD, Li CI.  2014.  Recent Oral Contraceptive Use by Formulation and Breast Cancer Risk among Women 20 to 49 Years of Age.. Cancer research. 74(15):4078-89. Abstract
Beasley JM, Schenk JM, Ludman E, Lampe JW, Reed SD, Grothaus L, Newton KM.  2010.  Brief telephone intervention increases soy intake in peri- and postmenopausal US women: the Herbal Alternatives Trial (HALT).. Journal of the American Dietetic Association. 110(8):1189-97. Abstract
C
Carpenter JS, Jones SMW, Studts CR, Heiman JR, Reed SD, Newton KM, Guthrie KA, Larson JC, Cohen LS, Freeman EW et al..  2016.  Female Sexual Function Index Short Version: A MsFLASH Item Response Analysis.. Archives of sexual behavior. Abstract
Carpenter JS, Reed SD, Guthrie KA, Larson JC, Newton KM, Lau JR, Learman LA, Shifren JL.  2015.  Using an FSDS-R Item to Screen for Sexually Related Distress: A MsFLASH Analysis.. Sexual medicine. 3(1):7-13. Abstract
Carpenter JS, Guthrie KA, Larson JC, Freeman EW, Joffe H, Reed SD, Ensrud KE, LaCroix AZ.  2012.  Effect of escitalopram on hot flash interference: a randomized, controlled trial.. Fertility and sterility. 97(6):1399-1404.e1. Abstract
Cohen LS, Joffe H, Guthrie KA, Ensrud KE, Freeman M, Carpenter JS, Learman LA, Newton KM, Reed SD, Manson JE et al..  2014.  Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial.. Menopause (New York, N.Y.). 21(4):347-54. Abstract
E
Ensrud KE, Joffe H, Guthrie KA, Larson JC, Reed SD, Newton KM, Sternfeld B, LaCroix AZ, Landis CA, Woods NF et al..  2012.  Effect of escitalopram on insomnia symptoms and subjective sleep quality in healthy perimenopausal and postmenopausal women with hot flashes: a randomized controlled trial.. Menopause (New York, N.Y.). Abstract
Epplein M, Reed SD, Voigt LF, Newton KM, Holt VL, Weiss NS.  2008.  Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history.. American journal of epidemiology. 168(6):563-70;discussion571-6. Abstract
Epplein M, Reed SD, Voigt LF, Newton KM, Holt VL, Weiss NS.  2009.  Endometrial hyperplasia risk in relation to recent use of oral contraceptives and hormone therapy.. Annals of epidemiology. 19(1):1-7. Abstract
F
Freeman EW, Guthrie KA, Caan B, Sternfeld B, Cohen LS, Joffe H, Carpenter JS, Anderson GL, Larson JC, Ensrud KE et al..  2011.  Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.. JAMA : the journal of the American Medical Association. 305(3):267-74. Abstract
G
Gray KE, Wallace ER, Nelson KR, Reed SD, Schiff MA.  2012.  Population-based study of risk factors for severe maternal morbidity.. Paediatric and perinatal epidemiology. 26(6):506-14. Abstract
Guthrie KA, LaCroix AZ, Ensrud KE, Joffe H, Newton KM, Reed SD, Caan B, Carpenter JS, Cohen LS, Freeman EW et al..  2015.  Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms.. Obstetrics and gynecology. 126(2):413-22. Abstract
J
Joffe H, Guthrie KA, LaCroix AZ, Reed SD, Ensrud KE, Manson JE, Newton KM, Freeman EW, Anderson GL, Larson JC et al..  2014.  Low-Dose Estradiol and the Serotonin-Norepinephrine Reuptake Inhibitor Venlafaxine for Vasomotor Symptoms: A Randomized Clinical Trial.. JAMA internal medicine. Abstract
Jones SMW, Guthrie KA, LaCroix AZ, Sternfeld B, Landis CA, Reed SD, Dunn A, Caan B, Cohen LS, Hunt J et al..  2015.  Is heart rate variability associated with frequency and intensity of vasomotor symptoms among healthy perimenopausal and postmenopausal women? Clinical autonomic research : official journal of the Clinical Autonomic Research Society. Abstract
Jones SMW, Guthrie KA, Reed SD, Landis CA, Sternfeld B, LaCroix AZ, Dunn A, Burr RL, Newton KM.  2016.  A yoga & exercise randomized controlled trial for vasomotor symptoms: Effects on heart rate variability.. Complementary therapies in medicine. 26:66-71. Abstract
K
Kissel HD, Paulson TG, Liu K, Li X, Swisher E, Garcia R, Sanchez CA, Reid BJ, Reed SD, Doherty JA.  2013.  Feasibility of RNA and DNA extraction from fresh pipelle and archival endometrial tissues for use in gene expression and SNP arrays.. Obstetrics and gynecology international. 2013:576842. Abstract
L
LaCroix AZ, Freeman EW, Larson J, Carpenter JS, Joffe H, Reed SD, Newton KM, Seguin RA, Sternfeld B, Cohen L et al..  2012.  Effects of escitalopram on menopause-specific quality of life and pain in healthy menopausal women with hot flashes: A randomized controlled trial.. Maturitas. Abstract
Lakey SL, Reed SD, LaCroix AZ, Grothaus L, Newton KM.  2010.  Self-reported changes in providers' hormone therapy prescribing and counseling practices after the Women's Health Initiative.. Journal of women's health (2002). 19(12):2175-81. Abstract
Lannon SMR, Guthrie KA, Reed SD, Gammill HS.  2013.  Mode of delivery at periviable gestational ages: impact on subsequent reproductive outcomes.. Journal of perinatal medicine. :1-7. Abstract
M
McCurry SM, Guthrie KA, Morin CM, Woods NF, Landis CA, Ensrud KE, Larson JC, Joffe H, Cohen LS, Hunt JR et al..  2016.  Telephone-Based Cognitive Behavioral Therapy for Insomnia in Perimenopausal and Postmenopausal Women With Vasomotor Symptoms: A MsFLASH Randomized Clinical Trial.. JAMA internal medicine. 176(7):913-20. Abstract
Miller LM, Lampe JW, Newton KM, Gundersen G, Fuller S, Reed SD, Frankenfeld CL.  2017.  Being overweight or obese is associated with harboring a gut microbial community not capable of metabolizing the soy isoflavone daidzein to O-desmethylangolensin in peri- and post-menopausal women.. Maturitas. 99:37-42. Abstract
Mitchell CM, Srinivasan S, Zhan X, Wu MC, Reed SD, Guthrie KA, LaCroix AZ, Fiedler T, Munch M, Liu C et al..  2017.  Vaginal microbiota and genitourinary menopausal symptoms: a cross-sectional analysis.. Menopause (New York, N.Y.). Abstract